Page 32 - Breakthrough Device News Today

February 2, 2022—MedAlliance, a Switzerland-based medical technology company, announced it has acquired its Japanese partner, MDK Medical, a vas

REDUCE LAP-HF II study defines treatable HFpEF patient population for atrial shunt therapy TEWKSBURY, Mass., Feb. 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming

/PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced results from its REDUCE LAP-HF II...

TEWKSBURY, Mass., Feb. 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today...

/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today...

/PRNewswire/ -- Checkpoint Surgical, Inc., the leader in intraoperative nerve repair stimulation technology, today announced it has enrolled the first patient...

The patient was enrolled at Ohio State University, one of four sites enrolling patients in the double-blind, randomized clinical trial of Checkpoint's BEST (Brief Electrical Stimulation Therapy) system. Checkpoint Surgical said the other participating sites are the Medical College of Wisconsin, Northwestern University and Walter Reed National Military Medical Center.

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - January 20, 2022) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) (Neovasc or the Company) today announced the publication of an article

/PRNewswire/ -- Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces the...

THE HAGUE, Netherlands, Jan. 19, 2022 /PRNewswire/ -- Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces